Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3.10M | $759.0M | 5.93% | -809.1K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 1.98M | $485.0M | 3.79% | -74.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.97M | $480.0M | 3.76% | +27.3K | 2026-06-30 |
| Invesco Ltd. | 1.67M | $409.0M | 3.20% | +374.0K | 2026-06-30 |
| FMR LLC | 1.54M | $376.0M | 2.94% | -27.8K | 2026-06-30 |
| Geode Capital Management, LLC | 967.2K | $236.0M | 1.85% | -195.8K | 2026-06-30 |
| Morgan Stanley | 804.1K | $196.0M | 1.54% | +327.4K | 2026-06-30 |
| State Street Corp | 785.7K | $192.0M | 1.50% | -201.1K | 2026-06-30 |
| Jane Street Group, LLC | 749.8K | $183.0M | 1.43% | +553.5K | 2026-06-30 |
| Deep Track Capital, LP | 700.0K | $171.0M | 1.34% | -400.0K | 2026-06-30 |
